Pharmaversity® https://www.schott-pharma.com/ en-us © 2023 SCHOTT Pharmaversity™ Education by experts for experts in drug containment and delivery solutions, Pharmaversity® is an inspirational networking hub for pharmaceutical companies to gain exclusive insight and scientific knowledge of drug containment and delivery solutions from the world’s leading glass and polymer experts. https://megaphone.imgix.net/podcasts/64669f68-3292-11ee-a2ad-ab061a234ed8/image/SCH-Pharma_Pharmaversity-Podcast-Cover_20231114.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Pharmaversity® https://www.schott-pharma.com/ no episodic SCHOTT Pharma Education by experts for experts in drug containment and delivery solutions, Pharmaversity® is an inspirational networking hub for pharmaceutical companies to gain exclusive insight and scientific knowledge of drug containment and delivery solutions from the world’s leading glass and polymer experts. Education by experts for experts in drug containment and delivery solutions, Pharmaversity® is an inspirational networking hub for pharmaceutical companies to gain exclusive insight and scientific knowledge of drug containment and delivery solutions from the world’s leading glass and polymer experts.

]]> SCHOTT Pharma Cold storage for prefilled polymer syringes, discover the journey from -80 to -180°C Discover how prefilled syringes withstand ultra-cold storage from -80°C to -180°C without compromising integrity. Join our webinar to explore key insights on container closure integrity, silicone distribution, and mechanical performance—proven stable under extreme conditions. Learn about testing methods, critical data, and what this means for the future of cell and gene cold chain solutions. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 09 Jul 2025 13:00:00 -0000 full SCHOTT Pharma Discover how prefilled syringes withstand ultra-cold storage from -80°C to -180°C without compromising integrity. Join our webinar to explore key insights on container closure integrity, silicone distribution, and mechanical performance—proven stable under extreme conditions. Learn about testing methods, critical data, and what this means for the future of cell and gene cold chain solutions. Learn more about your ad choices. Visit megaphone.fm/adchoices Discover how prefilled syringes withstand ultra-cold storage from -80°C to -180°C without compromising integrity. Join our webinar to explore key insights on container closure integrity, silicone distribution, and mechanical performance—proven stable under extreme conditions. Learn about testing methods, critical data, and what this means for the future of cell and gene cold chain solutions.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 553 How to choose the right vial Part II - spot on fill-and-finish, lyophilization and freezing: selection criteria & solutions to improve efficiency When it comes to drug containment, not only the stability of the drug plays a crucial role, but also the stability of the container itself - an optimized geometry can help to avoid breakage, during fill-and-finish as well as during storage. Resulting in safeguarding the patient and improving efficiency. In addition, high rejections rates due to cosmetic defects or due to fogging during lyophilization also result in elevated costs - even more crucial if high value drugs are affected. This Pharmaversity session will demonstrate how the choice of the vial can contribute to improve fill-and-finish efficiency and which parameters need to be considered.  Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 03 Jul 2025 13:00:00 -0000 full SCHOTT Pharma When it comes to drug containment, not only the stability of the drug plays a crucial role, but also the stability of the container itself - an optimized geometry can help to avoid breakage, during fill-and-finish as well as during storage. Resulting in safeguarding the patient and improving efficiency. In addition, high rejections rates due to cosmetic defects or due to fogging during lyophilization also result in elevated costs - even more crucial if high value drugs are affected. This Pharmaversity session will demonstrate how the choice of the vial can contribute to improve fill-and-finish efficiency and which parameters need to be considered.  Learn more about your ad choices. Visit megaphone.fm/adchoices When it comes to drug containment, not only the stability of the drug plays a crucial role, but also the stability of the container itself - an optimized geometry can help to avoid breakage, during fill-and-finish as well as during storage. Resulting in safeguarding the patient and improving efficiency.

In addition, high rejections rates due to cosmetic defects or due to fogging during lyophilization also result in elevated costs - even more crucial if high value drugs are affected.

This Pharmaversity session will demonstrate how the choice of the vial can contribute to improve fill-and-finish efficiency and which parameters need to be considered. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1001 Core Vials – how statistical process control elevates your fill-and-finish efficiency Good-quality pharmaceutical containers are not only a prerequisite for the safe storage and delivery of drug products, but they also have a positive impact on fill-and-finish processes. The more uniform a container is, the smoother it runs on the fill-and-finish line, resulting in lower container-related rejection rates. In this Pharmaversity session you will get insights on how you can unlock fill-and-finish Excellence with Core Vials. Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 26 Jun 2025 13:00:00 -0000 full SCHOTT Pharma Good-quality pharmaceutical containers are not only a prerequisite for the safe storage and delivery of drug products, but they also have a positive impact on fill-and-finish processes. The more uniform a container is, the smoother it runs on the fill-and-finish line, resulting in lower container-related rejection rates. In this Pharmaversity session you will get insights on how you can unlock fill-and-finish Excellence with Core Vials. Learn more about your ad choices. Visit megaphone.fm/adchoices Good-quality pharmaceutical containers are not only a prerequisite for the safe storage and delivery of drug products, but they also have a positive impact on fill-and-finish processes. The more uniform a container is, the smoother it runs on the fill-and-finish line, resulting in lower container-related rejection rates. In this Pharmaversity session you will get insights on how you can unlock fill-and-finish Excellence with Core Vials.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 893 Speed, Stability, Efficiency: How the next generation of prefilled polymer syringes redefines healthcare Prefilled polymer syringes have significantly enhanced the safety and effectiveness of infusion therapy in hospitals, moving away from traditional vial-and-syringe systems. Despite these advancements, hospitals still encounter various challenges, such as high drug waste due to unclear packaging, manual tray preparation, and storage issues. Additionally, pharmaceutical manufacturers face stringent regulatory requirements that can delay the development of combination products. Join our webinar to explore an innovative solution that addresses these challenges, improving operational efficiency, ensuring long shelf-life efficacy, and accelerating time to market. Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 24 Mar 2025 13:16:00 -0000 full SCHOTT Pharma Prefilled polymer syringes have significantly enhanced the safety and effectiveness of infusion therapy in hospitals, moving away from traditional vial-and-syringe systems. Despite these advancements, hospitals still encounter various challenges, such as high drug waste due to unclear packaging, manual tray preparation, and storage issues. Additionally, pharmaceutical manufacturers face stringent regulatory requirements that can delay the development of combination products. Join our webinar to explore an innovative solution that addresses these challenges, improving operational efficiency, ensuring long shelf-life efficacy, and accelerating time to market. Learn more about your ad choices. Visit megaphone.fm/adchoices Prefilled polymer syringes have significantly enhanced the safety and effectiveness of infusion therapy in hospitals, moving away from traditional vial-and-syringe systems. Despite these advancements, hospitals still encounter various challenges, such as high drug waste due to unclear packaging, manual tray preparation, and storage issues. Additionally, pharmaceutical manufacturers face stringent regulatory requirements that can delay the development of combination products.

Join our webinar to explore an innovative solution that addresses these challenges, improving operational efficiency, ensuring long shelf-life efficacy, and accelerating time to market.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 756 Decarbonizing the glass packaging supply chain with FIOLAX® Pro Climate change stands as one of the most pressing challenges of our time, demanding innovative solutions to decarbonize production and supply chains globally. Over 7,000 companies, including 19 of the top 20 pharmaceutical firms, have committed to science-based targets to ensure a reliable and scientific approach to this issue. It's time to share a blueprint for drastically reducing emissions with a broader audience. Join our webinar to discover the future-proof pharma glass tubing, FIOLAX® Pro. Learn how this innovative electrified melting technology reduces the CO2 footprint of primary packaging containers, paving the way for a sustainable future. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 19 Mar 2025 15:30:00 -0000 full SCHOTT Pharma Climate change stands as one of the most pressing challenges of our time, demanding innovative solutions to decarbonize production and supply chains globally. Over 7,000 companies, including 19 of the top 20 pharmaceutical firms, have committed to science-based targets to ensure a reliable and scientific approach to this issue. It's time to share a blueprint for drastically reducing emissions with a broader audience. Join our webinar to discover the future-proof pharma glass tubing, FIOLAX® Pro. Learn how this innovative electrified melting technology reduces the CO2 footprint of primary packaging containers, paving the way for a sustainable future. Learn more about your ad choices. Visit megaphone.fm/adchoices Climate change stands as one of the most pressing challenges of our time, demanding innovative solutions to decarbonize production and supply chains globally. Over 7,000 companies, including 19 of the top 20 pharmaceutical firms, have committed to science-based targets to ensure a reliable and scientific approach to this issue.

It's time to share a blueprint for drastically reducing emissions with a broader audience. Join our webinar to discover the future-proof pharma glass tubing, FIOLAX® Pro. Learn how this innovative electrified melting technology reduces the CO2 footprint of primary packaging containers, paving the way for a sustainable future.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1329 How to secure robust drug delivery: Performance requirements for RTU cartridges The integrity of pharmaceutical packaging is vital, especially for biologics, where drug-container interactions can significantly impact stability and efficacy. In the upcoming webinar we will explore key considerations in selecting and optimizing ready-to-use (RTU) cartridges for complex drug formulations. Topics include material compatibility, leachable profiles, and strategies to mitigate risks such as delamination. We will also discuss drug-container interactions and their implications for long-term storage. Additionally, critical performance parameters like break-loose gliding force (BLGF) and functional stability will be covered to ensure seamless drug administration. Join the webinar to gain valuable insights into optimizing packaging solutions for the next generation of drug delivery systems with RTU cartridges. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 12 Mar 2025 15:30:00 -0000 full SCHOTT Pharma The integrity of pharmaceutical packaging is vital, especially for biologics, where drug-container interactions can significantly impact stability and efficacy. In the upcoming webinar we will explore key considerations in selecting and optimizing ready-to-use (RTU) cartridges for complex drug formulations. Topics include material compatibility, leachable profiles, and strategies to mitigate risks such as delamination. We will also discuss drug-container interactions and their implications for long-term storage. Additionally, critical performance parameters like break-loose gliding force (BLGF) and functional stability will be covered to ensure seamless drug administration. Join the webinar to gain valuable insights into optimizing packaging solutions for the next generation of drug delivery systems with RTU cartridges. Learn more about your ad choices. Visit megaphone.fm/adchoices The integrity of pharmaceutical packaging is vital, especially for biologics, where drug-container interactions can significantly impact stability and efficacy. In the upcoming webinar we will explore key considerations in selecting and optimizing ready-to-use (RTU) cartridges for complex drug formulations. Topics include material compatibility, leachable profiles, and strategies to mitigate risks such as delamination. We will also discuss drug-container interactions and their implications for long-term storage. Additionally, critical performance parameters like break-loose gliding force (BLGF) and functional stability will be covered to ensure seamless drug administration.

Join the webinar to gain valuable insights into optimizing packaging solutions for the next generation of drug delivery systems with RTU cartridges.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 933 Simplifying large volume subcutaneous drug administrations - SCHOTT TOPPAC® COC polymer syringes with KORU near body devices The pharmaceutical industry continues to trend towards large volume subcutaneous drug formulations, accompanied by a strong emphasis on simplifying drug administration. However, dosage volumes of 10 mL and higher present specific challenges, including limited availability of qualified primary packaging, shortcomings in On Body Devices, and the drawbacks of manual push drug administration. The SCHOTT TOPPAC® COC polymer pre-fillable syringes, in combination with KORU’s Near Body Devices, effectively address these challenges, particularly in the 10 to 50 mL volume range. Join this Pharmaversity session to discover how this integrated system: - Mitigates risks in development and routine drug administration - Enhances user experience for healthcare professionals and self-administration - Accelerates time to market - Contributes to sustainability efforts Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 11 Dec 2024 14:45:00 -0000 full SCHOTT Pharma The pharmaceutical industry continues to trend towards large volume subcutaneous drug formulations, accompanied by a strong emphasis on simplifying drug administration. However, dosage volumes of 10 mL and higher present specific challenges, including limited availability of qualified primary packaging, shortcomings in On Body Devices, and the drawbacks of manual push drug administration. The SCHOTT TOPPAC® COC polymer pre-fillable syringes, in combination with KORU’s Near Body Devices, effectively address these challenges, particularly in the 10 to 50 mL volume range. Join this Pharmaversity session to discover how this integrated system: - Mitigates risks in development and routine drug administration - Enhances user experience for healthcare professionals and self-administration - Accelerates time to market - Contributes to sustainability efforts Learn more about your ad choices. Visit megaphone.fm/adchoices The pharmaceutical industry continues to trend towards large volume subcutaneous drug formulations, accompanied by a strong emphasis on simplifying drug administration. However, dosage volumes of 10 mL and higher present specific challenges, including limited availability of qualified primary packaging, shortcomings in On Body Devices, and the drawbacks of manual push drug administration.

The SCHOTT TOPPAC® COC polymer pre-fillable syringes, in combination with KORU’s Near Body Devices, effectively address these challenges, particularly in the 10 to 50 mL volume range.

Join this Pharmaversity session to discover how this integrated system:

- Mitigates risks in development and routine drug administration

- Enhances user experience for healthcare professionals and self-administration

- Accelerates time to market

- Contributes to sustainability efforts

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 841 Advancing insights into large volume subcutaneous autoinjections Despite advancements in subcutaneous (SC) autoinjection, comprehensive insights are still limited. SC delivery of biologics faces challenges such as drug volume, viscosity, and user injection time. While adjunct molecules have improved absorption for larger doses, significant gaps remain in SC drug development. Join this joint webinar by SHL Medical and SCHOTT Pharma, where we will present findings from a literature review, feasibility testing of 60-second injections, and characterization of 5.0 mL cartridges. These studies are designed to deepen understanding and drive progress in large-volume autoinjection delivery. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 27 Nov 2024 15:27:58 -0000 full SCHOTT Pharma Despite advancements in subcutaneous (SC) autoinjection, comprehensive insights are still limited. SC delivery of biologics faces challenges such as drug volume, viscosity, and user injection time. While adjunct molecules have improved absorption for larger doses, significant gaps remain in SC drug development. Join this joint webinar by SHL Medical and SCHOTT Pharma, where we will present findings from a literature review, feasibility testing of 60-second injections, and characterization of 5.0 mL cartridges. These studies are designed to deepen understanding and drive progress in large-volume autoinjection delivery. Learn more about your ad choices. Visit megaphone.fm/adchoices Despite advancements in subcutaneous (SC) autoinjection, comprehensive insights are still limited. SC delivery of biologics faces challenges such as drug volume, viscosity, and user injection time. While adjunct molecules have improved absorption for larger doses, significant gaps remain in SC drug development.

Join this joint webinar by SHL Medical and SCHOTT Pharma, where we will present findings from a literature review, feasibility testing of 60-second injections, and characterization of 5.0 mL cartridges. These studies are designed to deepen understanding and drive progress in large-volume autoinjection delivery.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1059 How to choose the right vial for next-generation therapies Primary packaging is a crucial component of drug formulation. Even the most advanced medication can lose its efficacy if stored in a container that fails to maintain its stability over time. With the growing prevalence of biologics, the range of molecules and applications continues to expand, leading to increasingly diverse requirements for primary packaging. For example, more than 50% of biologics require lyophilization, which can introduce challenges such as "fogging." Additionally, some molecules are highly sensitive to glass leachables, particularly with low-fill volumes, while others may adsorb to the container's surface, affecting dosage accuracy or necessitating overfilling. At SCHOTT Pharma, we offer the most extensive range of vial solutions designed to address these specific challenges. Join our upcoming webinar to explore our advanced vial solutions, tailored to meet the demands of next-generation drugs. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 20 Nov 2024 14:12:18 -0000 How to choose the right vial for next-generation therapies full SCHOTT Pharma Primary packaging is a crucial component of drug formulation. Even the most advanced medication can lose its efficacy if stored in a container that fails to maintain its stability over time. With the growing prevalence of biologics, the range of molecules and applications continues to expand, leading to increasingly diverse requirements for primary packaging. For example, more than 50% of biologics require lyophilization, which can introduce challenges such as "fogging." Additionally, some molecules are highly sensitive to glass leachables, particularly with low-fill volumes, while others may adsorb to the container's surface, affecting dosage accuracy or necessitating overfilling. At SCHOTT Pharma, we offer the most extensive range of vial solutions designed to address these specific challenges. Join our upcoming webinar to explore our advanced vial solutions, tailored to meet the demands of next-generation drugs. Learn more about your ad choices. Visit megaphone.fm/adchoices Primary packaging is a crucial component of drug formulation. Even the most advanced medication can lose its efficacy if stored in a container that fails to maintain its stability over time.

With the growing prevalence of biologics, the range of molecules and applications continues to expand, leading to increasingly diverse requirements for primary packaging. For example, more than 50% of biologics require lyophilization, which can introduce challenges such as "fogging." Additionally, some molecules are highly sensitive to glass leachables, particularly with low-fill volumes, while others may adsorb to the container's surface, affecting dosage accuracy or necessitating overfilling.

At SCHOTT Pharma, we offer the most extensive range of vial solutions designed to address these specific challenges. Join our upcoming webinar to explore our advanced vial solutions, tailored to meet the demands of next-generation drugs.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1494 Addressing advanced stakeholder needs in biologics: a case study on prefillable glass syringes and coated plungers The use of biologics is a rapidly growing field in the treatment of chronic diseases, both in hospitals and through patient self-medication at home. Pharma companies' development pipelines for injectable biologics are well-filled, projecting a high demand for high-end container solutions. These solutions must be robust and reliable to address the numerous challenges of biologics, such as drug-container interactions, particles, and functional requirements. In this joint Pharmaversity® session with Datwyler, we will explore how the syriQ BioPure® prefillable glass syringe (PFS) platform and the spray-coated NeoFlex™ plunger portfolio are addressing stakeholder needs in biologics - from pharmaceutical requirements to user needs and processability, including important topics like drug compatibility, device integration, supply chain security, sustainability, and the latest regulatory considerations.   Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 10 Jul 2024 07:47:46 -0000 Addressing advanced stakeholder needs in biologics: a case study on prefillable glass syringes and coated plungers full SCHOTT Pharma The use of biologics is a rapidly growing field in the treatment of chronic diseases, both in hospitals and through patient self-medication at home. Pharma companies' development pipelines for injectable biologics are well-filled, projecting a high demand for high-end container solutions. These solutions must be robust and reliable to address the numerous challenges of biologics, such as drug-container interactions, particles, and functional requirements. In this joint Pharmaversity® session with Datwyler, we will explore how the syriQ BioPure® prefillable glass syringe (PFS) platform and the spray-coated NeoFlex™ plunger portfolio are addressing stakeholder needs in biologics - from pharmaceutical requirements to user needs and processability, including important topics like drug compatibility, device integration, supply chain security, sustainability, and the latest regulatory considerations.   Learn more about your ad choices. Visit megaphone.fm/adchoices The use of biologics is a rapidly growing field in the treatment of chronic diseases, both in hospitals and through patient self-medication at home. Pharma companies' development pipelines for injectable biologics are well-filled, projecting a high demand for high-end container solutions. These solutions must be robust and reliable to address the numerous challenges of biologics, such as drug-container interactions, particles, and functional requirements.

In this joint Pharmaversity® session with Datwyler, we will explore how the syriQ BioPure® prefillable glass syringe (PFS) platform and the spray-coated NeoFlex™ plunger portfolio are addressing stakeholder needs in biologics - from pharmaceutical requirements to user needs and processability, including important topics like drug compatibility, device integration, supply chain security, sustainability, and the latest regulatory considerations.  

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 840 Optimizing prefillable polymer syringe nest design for enhanced fill-and-finish In pharmaceutical manufacturing, operational efficiency is crucial for meeting production targets while ensuring product quality and cost-effectiveness. One impactful strategy is increasing the number of cavities per nest for prefilable polymer syringes. This enhancement maximizes conveyor space utilization, streamlines production processes, and supports sustainability objectives by minimizing material and energy consumption per unit. Join us in this joint Pharmaversity® session with Bausch+Ströbel to discover how this simple yet impactful adjustment can lead to significant improvements in efficiency, cost-effectiveness, and environmental responsibility for pharmaceutical manufacturers. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 26 Jun 2024 08:35:19 -0000 Optimizing prefillable polymer syringe nest design for enhanced fill-and-finish full SCHOTT Pharma In pharmaceutical manufacturing, operational efficiency is crucial for meeting production targets while ensuring product quality and cost-effectiveness. One impactful strategy is increasing the number of cavities per nest for prefilable polymer syringes. This enhancement maximizes conveyor space utilization, streamlines production processes, and supports sustainability objectives by minimizing material and energy consumption per unit. Join us in this joint Pharmaversity® session with Bausch+Ströbel to discover how this simple yet impactful adjustment can lead to significant improvements in efficiency, cost-effectiveness, and environmental responsibility for pharmaceutical manufacturers. Learn more about your ad choices. Visit megaphone.fm/adchoices In pharmaceutical manufacturing, operational efficiency is crucial for meeting production targets while ensuring product quality and cost-effectiveness.

One impactful strategy is increasing the number of cavities per nest for prefilable polymer syringes.

This enhancement maximizes conveyor space utilization, streamlines production processes, and supports sustainability objectives by minimizing material and energy consumption per unit.

Join us in this joint Pharmaversity® session with Bausch+Ströbel to discover how this simple yet impactful adjustment can lead to significant improvements in efficiency, cost-effectiveness, and environmental responsibility for pharmaceutical manufacturers.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 700 Antibody- and Radionuclide Drug Conjugates: Advanced vial solutions for cutting-edge cancer treatments Latest innovations in drug technologies seek to bring cancer treatment to the next level. For example, using the targeting ability of monoclonal antibodies in combination with a cytotoxic (Antibody Drug Conjugates) or radioactive molecule (Radionuclide Drug Conjugates). These medicines offer a promising alternative to common radiation or chemotherapy, potentially increasing effectiveness and reducing side effects for patients due to their precision. However, these drugs have complex structures that pose certain challenges in processing and storage in primary packaging. Stability issues often necessitate lyophilization, while liquid formulations can be affected by glass leachables. Additionally, light sensitivity may present further hurdles. Join this Pharmaversity® session and learn what vial solutions SCHOTT Pharma offers to address these challenges. Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 03 Jun 2024 11:00:00 -0000 Antibody- and Radionuclide Drug Conjugates: Advanced vial solutions for cutting-edge cancer treatments full SCHOTT Pharma Latest innovations in drug technologies seek to bring cancer treatment to the next level. For example, using the targeting ability of monoclonal antibodies in combination with a cytotoxic (Antibody Drug Conjugates) or radioactive molecule (Radionuclide Drug Conjugates). These medicines offer a promising alternative to common radiation or chemotherapy, potentially increasing effectiveness and reducing side effects for patients due to their precision. However, these drugs have complex structures that pose certain challenges in processing and storage in primary packaging. Stability issues often necessitate lyophilization, while liquid formulations can be affected by glass leachables. Additionally, light sensitivity may present further hurdles. Join this Pharmaversity® session and learn what vial solutions SCHOTT Pharma offers to address these challenges. Learn more about your ad choices. Visit megaphone.fm/adchoices Latest innovations in drug technologies seek to bring cancer treatment to the next level. For example, using the targeting ability of monoclonal antibodies in combination with a cytotoxic (Antibody Drug Conjugates) or radioactive molecule (Radionuclide Drug Conjugates). These medicines offer a promising alternative to common radiation or chemotherapy, potentially increasing effectiveness and reducing side effects for patients due to their precision.

However, these drugs have complex structures that pose certain challenges in processing and storage in primary packaging. Stability issues often necessitate lyophilization, while liquid formulations can be affected by glass leachables. Additionally, light sensitivity may present further hurdles. Join this Pharmaversity® session and learn what vial solutions SCHOTT Pharma offers to address these challenges.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1399 How to comply with EU GMP Annex I using RTU containers Contamination control programming, as defined in EU Annex I, mitigates risk. This webinar highlights elements of the SCHOTT Pharma Contamination Control Strategy (CCS) and strategies for compliance with GMP standards. Integrating RTU containers with state-of-the-art filling concepts minimizes contamination risks, streamers validation processes, and enhances overall manufacturing efficiency. Compliance means aligning with regulations, optimizing processes, and elevating pharmaceutical manufacturing quality. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 19 Mar 2024 21:30:41 -0000 full SCHOTT Pharma Contamination control programming, as defined in EU Annex I, mitigates risk. This webinar highlights elements of the SCHOTT Pharma Contamination Control Strategy (CCS) and strategies for compliance with GMP standards. Integrating RTU containers with state-of-the-art filling concepts minimizes contamination risks, streamers validation processes, and enhances overall manufacturing efficiency. Compliance means aligning with regulations, optimizing processes, and elevating pharmaceutical manufacturing quality. Learn more about your ad choices. Visit megaphone.fm/adchoices Contamination control programming, as defined in EU Annex I, mitigates risk. This webinar highlights elements of the SCHOTT Pharma Contamination Control Strategy (CCS) and strategies for compliance with GMP standards. Integrating RTU containers with state-of-the-art filling concepts minimizes contamination risks, streamers validation processes, and enhances overall manufacturing efficiency. Compliance means aligning with regulations, optimizing processes, and elevating pharmaceutical manufacturing quality.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1018 What to test and what not to test, that is the question for your drug submission The road to drug submission can feel like an existential question through a labyrinth with a blindfold—exciting yet slightly terrifying. This webinar will delve into the complexities of drug submission, illuminating the path with insights into Testing Services for Combination Drug Products. Gain insights on streamlining your testing processes for regulatory compliance, accelerating your market submission, and elevating the assurance of your product’s quality and safety. Explore the capabilities of SCHOTT Pharma's PartnerLab, designed to transform intricate regulatory requirements into a seamless routine. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 13 Mar 2024 12:32:44 -0000 full SCHOTT Pharma The road to drug submission can feel like an existential question through a labyrinth with a blindfold—exciting yet slightly terrifying. This webinar will delve into the complexities of drug submission, illuminating the path with insights into Testing Services for Combination Drug Products. Gain insights on streamlining your testing processes for regulatory compliance, accelerating your market submission, and elevating the assurance of your product’s quality and safety. Explore the capabilities of SCHOTT Pharma's PartnerLab, designed to transform intricate regulatory requirements into a seamless routine. Learn more about your ad choices. Visit megaphone.fm/adchoices The road to drug submission can feel like an existential question through a labyrinth with a blindfold—exciting yet slightly terrifying. This webinar will delve into the complexities of drug submission, illuminating the path with insights into Testing Services for Combination Drug Products.

Gain insights on streamlining your testing processes for regulatory compliance, accelerating your market submission, and elevating the assurance of your product’s quality and safety. Explore the capabilities of SCHOTT Pharma's PartnerLab, designed to transform intricate regulatory requirements into a seamless routine.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1431 The rise of deep-cold storage drugs: Challenges and solutions with glass vials mRNA. saRNA. DNA drugs. Only some of the groundbreaking medical developments that offer new possibilities for treating different diseases. The stability of these biological drugs, until they are injected, is mainly achieved with storage at deep-cold temperatures. This brings several significant challenges for pharmaceutical companies. This webinar will explore the complexities of deep-cold requirements and unveil a novel glass solution – EVERIC® freeze. As the first glass vial with optimized strength for applications down to -80°C, EVERIC® freeze promises to redefine the biological drug storage landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 07 Mar 2024 13:26:31 -0000 full SCHOTT Pharma mRNA. saRNA. DNA drugs. Only some of the groundbreaking medical developments that offer new possibilities for treating different diseases. The stability of these biological drugs, until they are injected, is mainly achieved with storage at deep-cold temperatures. This brings several significant challenges for pharmaceutical companies. This webinar will explore the complexities of deep-cold requirements and unveil a novel glass solution – EVERIC® freeze. As the first glass vial with optimized strength for applications down to -80°C, EVERIC® freeze promises to redefine the biological drug storage landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices mRNA. saRNA. DNA drugs. Only some of the groundbreaking medical developments that offer new possibilities for treating different diseases. The stability of these biological drugs, until they are injected, is mainly achieved with storage at deep-cold temperatures. This brings several significant challenges for pharmaceutical companies.

This webinar will explore the complexities of deep-cold requirements and unveil a novel glass solution – EVERIC® freeze. As the first glass vial with optimized strength for applications down to -80°C, EVERIC® freeze promises to redefine the biological drug storage landscape.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1157 A stakeholder-centered development of large volume drug delivery solutions Larger subcutaneous injections are becoming more prominent due to recent advances in formulation development and new therapeutic areas. Therefore, novel large volume autoinjectors need to be developed to fulfill this new demand. As the interplay of device and container is crucial for a safe and reliable drug administration, a co-development between container and device manufacturers is a meaningful way to understand and address all relevant stakeholder needs. In this Pharmaversity® session experts from SCHOTT Pharma and Ypsomed will provide an insight into how pharmaceutical requirements, user needs, processability, and business requirements have guided the co-development of YpsoMate 5.5 autoinjector and syriQ BioPure® 5.5ml prefillable glass syringe. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 05 Dec 2023 14:00:00 -0000 A stakeholder-centered development of large volume drug delivery solutions full SCHOTT Pharma Larger subcutaneous injections are becoming more prominent due to recent advances in formulation development and new therapeutic areas. Therefore, novel large volume autoinjectors need to be developed to fulfill this new demand. As the interplay of device and container is crucial for a safe and reliable drug administration, a co-development between container and device manufacturers is a meaningful way to understand and address all relevant stakeholder needs. In this Pharmaversity® session experts from SCHOTT Pharma and Ypsomed will provide an insight into how pharmaceutical requirements, user needs, processability, and business requirements have guided the co-development of YpsoMate 5.5 autoinjector and syriQ BioPure® 5.5ml prefillable glass syringe. Learn more about your ad choices. Visit megaphone.fm/adchoices Larger subcutaneous injections are becoming more prominent due to recent advances in formulation development and new therapeutic areas. Therefore, novel large volume autoinjectors need to be developed to fulfill this new demand. As the interplay of device and container is crucial for a safe and reliable drug administration, a co-development between container and device manufacturers is a meaningful way to understand and address all relevant stakeholder needs.

In this Pharmaversity® session experts from SCHOTT Pharma and Ypsomed will provide an insight into how pharmaceutical requirements, user needs, processability, and business requirements have guided the co-development of YpsoMate 5.5 autoinjector and syriQ BioPure® 5.5ml prefillable glass syringe.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 621 How to choose the ideal packaging for your deep cold stored drug? A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage at deep cold temperatures. The functionality of the primary packaging is strongly impacted at these temperatures and limited market know-how is available. In this Pharmaversity™ session our experts will provide insight in how low temperature storage can influence the primary packaging and a science-based data package providing deep-dive on the container's functionality helping you to make a sound decision when choosing the container. Two solutions will be presented: one based on vials with optimized strength for applications down to -80°C and one based on prefillable syringes suitable for storage down to -100°C. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 15 Nov 2023 13:08:03 -0000 How to choose the ideal packaging for your deep cold stored drug? full SCHOTT Pharma A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage at deep cold temperatures. The functionality of the primary packaging is strongly impacted at these temperatures and limited market know-how is available. In this Pharmaversity™ session our experts will provide insight in how low temperature storage can influence the primary packaging and a science-based data package providing deep-dive on the container's functionality helping you to make a sound decision when choosing the container. Two solutions will be presented: one based on vials with optimized strength for applications down to -80°C and one based on prefillable syringes suitable for storage down to -100°C. Learn more about your ad choices. Visit megaphone.fm/adchoices A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage at deep cold temperatures. The functionality of the primary packaging is strongly impacted at these temperatures and limited market know-how is available.

In this Pharmaversity™ session our experts will provide insight in how low temperature storage can influence the primary packaging and a science-based data package providing deep-dive on the container's functionality helping you to make a sound decision when choosing the container. Two solutions will be presented: one based on vials with optimized strength for applications down to -80°C and one based on prefillable syringes suitable for storage down to -100°C.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1135 Safe and fast drug development: choose the right vial from the start During pharma development, goal number one is to find a formulation that keeps the drug stable and hence safe for the future patient. The more formulation options you have, the higher the likelihood that you find the most appropriate solution for the specific drug along its life cycle. Later re-formulations due to stability issues as e.g. particle formation or pH shift are time- and cost intensive. Learn in this session how EVERIC® pure, an enhanced Type I glass vial, increases your formulation options resulting in safer and faster time to market. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 08 Nov 2023 10:00:00 -0000 full SCHOTT Pharma This session will explore how EVERIC® pure, an advanced Type I glass vial, expands formulation possibilities, enhancing drug stability and safety, thereby accelerating market readiness. During pharma development, goal number one is to find a formulation that keeps the drug stable and hence safe for the future patient. The more formulation options you have, the higher the likelihood that you find the most appropriate solution for the specific drug along its life cycle. Later re-formulations due to stability issues as e.g. particle formation or pH shift are time- and cost intensive. Learn in this session how EVERIC® pure, an enhanced Type I glass vial, increases your formulation options resulting in safer and faster time to market. Learn more about your ad choices. Visit megaphone.fm/adchoices During pharma development, goal number one is to find a formulation that keeps the drug stable and hence safe for the future patient. The more formulation options you have, the higher the likelihood that you find the most appropriate solution for the specific drug along its life cycle. Later re-formulations due to stability issues as e.g. particle formation or pH shift are time- and cost intensive.

Learn in this session how EVERIC® pure, an enhanced Type I glass vial, increases your formulation options resulting in safer and faster time to market.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 909 Designing a pathway towards net-zero injection devices Today, most companies are aware of the need for future climate-neutral or net-zero pharmaceutical products. But, the question is how to get there. Our response is industry collaboration: With our partners in the Alliance to Zero we are conceptionalizing how the product carbon footprint of autoinjectors can be mitigated.With this presentation, we take you with us on the journey to zero: starting from assessing the footprint of today, upcoming or needed future regulations to the concept and starting points of a future circular supply chain. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 Designing a pathway towards net-zero injection devices full SCHOTT Pharma Today, most companies are aware of the need for future climate-neutral or net-zero pharmaceutical products. But, the question is how to get there. Our response is industry collaboration: With our partners in the Alliance to Zero we are conceptionalizing how the product carbon footprint of autoinjectors can be mitigated.With this presentation, we take you with us on the journey to zero: starting from assessing the footprint of today, upcoming or needed future regulations to the concept and starting points of a future circular supply chain. Learn more about your ad choices. Visit megaphone.fm/adchoices Today, most companies are aware of the need for future climate-neutral or net-zero pharmaceutical products. But, the question is how to get there. Our response is industry collaboration: With our partners in the Alliance to Zero we are conceptionalizing how the product carbon footprint of autoinjectors can be mitigated.

With this presentation, we take you with us on the journey to zero: starting from assessing the footprint of today, upcoming or needed future regulations to the concept and starting points of a future circular supply chain.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1012 no Vials for deep cold storage: key results A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage down to – 80 °C.At these low temperatures the vial behavior may be impacted in a way that flaws in combination with thermal stresses can lead to an increased risk of breakage although glass is thermally stable. Another question arising is if container closure integrity (CCI) is stable under these changed environmental conditions.Thorough CCI- and strength tests have been performed after storage at – 80 °C. Learn about the results in this webinar that can help you to understand the fit of vials for deep freezing temperatures. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 Vials for deep cold storage: key results full SCHOTT Pharma A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage down to – 80 °C.At these low temperatures the vial behavior may be impacted in a way that flaws in combination with thermal stresses can lead to an increased risk of breakage although glass is thermally stable. Another question arising is if container closure integrity (CCI) is stable under these changed environmental conditions.Thorough CCI- and strength tests have been performed after storage at – 80 °C. Learn about the results in this webinar that can help you to understand the fit of vials for deep freezing temperatures. Learn more about your ad choices. Visit megaphone.fm/adchoices A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage down to – 80 °C.

At these low temperatures the vial behavior may be impacted in a way that flaws in combination with thermal stresses can lead to an increased risk of breakage although glass is thermally stable. Another question arising is if container closure integrity (CCI) is stable under these changed environmental conditions.

Thorough CCI- and strength tests have been performed after storage at – 80 °C. Learn about the results in this webinar that can help you to understand the fit of vials for deep freezing temperatures.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 931 no Challenges and opportunities of RFID equipped prefilled syringes Providing lifesaving treatment is daily business for hospitals. However, the hospital setting is a notorious hectic place with drug shortages and inefficient and labor intensive steps as possible reasons for poorer patient care. Prefilled syringes (PFS) help in accelerate the drug administration process and reduce the medical errors, but more can be gained with equipping the PFS with RFID.  Learn at this podcast about the untapped potential to include RFID tags onto PFS. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 Challenges and opportunities of RFID equipped prefilled syringes full SCHOTT Pharma Providing lifesaving treatment is daily business for hospitals. However, the hospital setting is a notorious hectic place with drug shortages and inefficient and labor intensive steps as possible reasons for poorer patient care. Prefilled syringes (PFS) help in accelerate the drug administration process and reduce the medical errors, but more can be gained with equipping the PFS with RFID.  Learn at this podcast about the untapped potential to include RFID tags onto PFS. Learn more about your ad choices. Visit megaphone.fm/adchoices Providing lifesaving treatment is daily business for hospitals. However, the hospital setting is a notorious hectic place with drug shortages and inefficient and labor intensive steps as possible reasons for poorer patient care. Prefilled syringes (PFS) help in accelerate the drug administration process and reduce the medical errors, but more can be gained with equipping the PFS with RFID.  Learn at this podcast about the untapped potential to include RFID tags onto PFS.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1013 no How to optimize processes and usage of ampoules Ampoules were the first container developed to store injectable drugs. Still today is the most used container worldwide contributing to save lives around the globe.Learn at this webinar how to improve your filling process and get insights about how you can cope with common challenges associated with ampoule processing and handling. From an end user perspective, we will have a look on how the use of SCHOTT ampoules can safeguard patients from the opening of the ampoule to the protection against counterfeit. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 How to optimize processes and usage of ampoules full SCHOTT Pharma Ampoules were the first container developed to store injectable drugs. Still today is the most used container worldwide contributing to save lives around the globe.Learn at this webinar how to improve your filling process and get insights about how you can cope with common challenges associated with ampoule processing and handling. From an end user perspective, we will have a look on how the use of SCHOTT ampoules can safeguard patients from the opening of the ampoule to the protection against counterfeit. Learn more about your ad choices. Visit megaphone.fm/adchoices Ampoules were the first container developed to store injectable drugs. Still today is the most used container worldwide contributing to save lives around the globe.

Learn at this webinar how to improve your filling process and get insights about how you can cope with common challenges associated with ampoule processing and handling. From an end user perspective, we will have a look on how the use of SCHOTT ampoules can safeguard patients from the opening of the ampoule to the protection against counterfeit.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 747 no Cómo optimizar el procesado y uso de las ampollas Las ampollas fueron el primer contenedor desarrollado para almacenar medicamentos inyectables. Todavía hoy es el contenedor más utilizado a nivel mundial contribuyendo a salvar vidas en todo el mundo.Aprenda en este webinar cómo mejorar el proceso de llenado y obtenga información sobre cómo hacer frente a los desafíos comunes asociados con el procesamiento y manipulación de ampollas.Desde la perspectiva del usuario final, veremos cómo el uso de ampollas SCHOTT puede proteger a los pacientes desde la apertura de la ampolla hasta la protección contra la falsificación. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 Cómo optimizar el procesado y uso de las ampollas full SCHOTT Pharma Las ampollas fueron el primer contenedor desarrollado para almacenar medicamentos inyectables. Todavía hoy es el contenedor más utilizado a nivel mundial contribuyendo a salvar vidas en todo el mundo.Aprenda en este webinar cómo mejorar el proceso de llenado y obtenga información sobre cómo hacer frente a los desafíos comunes asociados con el procesamiento y manipulación de ampollas.Desde la perspectiva del usuario final, veremos cómo el uso de ampollas SCHOTT puede proteger a los pacientes desde la apertura de la ampolla hasta la protección contra la falsificación. Learn more about your ad choices. Visit megaphone.fm/adchoices Las ampollas fueron el primer contenedor desarrollado para almacenar medicamentos inyectables. Todavía hoy es el contenedor más utilizado a nivel mundial contribuyendo a salvar vidas en todo el mundo.

Aprenda en este webinar cómo mejorar el proceso de llenado y obtenga información sobre cómo hacer frente a los desafíos comunes asociados con el procesamiento y manipulación de ampollas.

Desde la perspectiva del usuario final, veremos cómo el uso de ampollas SCHOTT puede proteger a los pacientes desde la apertura de la ampolla hasta la protección contra la falsificación.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 834 no A new lab method to assess strength of different vials It is crucial to reliably evaluate the effect of bulk fill-and-finish processing on cosmetic as well as on strength-affecting defects. Unfortunately, it requires a high effort to perform a dedicated line trial to assess different vial features, which is of particular interest during product development. Due to this challenge, a laboratory method has been designed in order to generate characteristic fill-and-finish line defects on vials in a reproducible manner. In this session, the method as well as first results will be presented. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 A new lab method to assess strength of different vials full SCHOTT Pharma It is crucial to reliably evaluate the effect of bulk fill-and-finish processing on cosmetic as well as on strength-affecting defects. Unfortunately, it requires a high effort to perform a dedicated line trial to assess different vial features, which is of particular interest during product development. Due to this challenge, a laboratory method has been designed in order to generate characteristic fill-and-finish line defects on vials in a reproducible manner. In this session, the method as well as first results will be presented. Learn more about your ad choices. Visit megaphone.fm/adchoices It is crucial to reliably evaluate the effect of bulk fill-and-finish processing on cosmetic as well as on strength-affecting defects. Unfortunately, it requires a high effort to perform a dedicated line trial to assess different vial features, which is of particular interest during product development. Due to this challenge, a laboratory method has been designed in order to generate characteristic fill-and-finish line defects on vials in a reproducible manner. 
In this session, the method as well as first results will be presented.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1025 no Reconsidering fill-and-finish processes in drug manufacturing Pharmaceutical companies are continuously evaluating the efficiency of their filling lines to achieve lower costs, better quality and higher flexibility. Three slightly contradictory goals require a fundamental rethinking of manufacturing processes. This session addresses the core challenges and how ready-to-use (RTU) vials like adaptiQ® from SCHOTT Pharma can help to improve the drug quality and accelerate time-to-market and as a result reduce the Total Cost of Ownership of fill-and-finish processes. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 Reconsidering fill-and-finish processes in drug manufacturing full SCHOTT Pharma Pharmaceutical companies are continuously evaluating the efficiency of their filling lines to achieve lower costs, better quality and higher flexibility. Three slightly contradictory goals require a fundamental rethinking of manufacturing processes. This session addresses the core challenges and how ready-to-use (RTU) vials like adaptiQ® from SCHOTT Pharma can help to improve the drug quality and accelerate time-to-market and as a result reduce the Total Cost of Ownership of fill-and-finish processes. Learn more about your ad choices. Visit megaphone.fm/adchoices Pharmaceutical companies are continuously evaluating the efficiency of their filling lines to achieve lower costs, better quality and higher flexibility. Three slightly contradictory goals require a fundamental rethinking of manufacturing processes. This session addresses the core challenges and how ready-to-use (RTU) vials like adaptiQ® from SCHOTT Pharma can help to improve the drug quality and accelerate time-to-market and as a result reduce the Total Cost of Ownership of fill-and-finish processes.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 901 no Enabling safe and easy administration of large volume injections The combination of YpsoDose and the 10 mL cartriQ® shows how innovative capabilities and expertise can address perfect fit for use, efficient processing as well as safe and easy administration for injectable medication. SCHOTT Pharma’s expertise in drug containment and delivery solutions and Ypsomed’s expertise in injection systems make them the ideal partners to present their joint solution in this session. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 11:00:00 -0000 Enabling safe and easy administration of large volume injections full SCHOTT Pharma The combination of YpsoDose and the 10 mL cartriQ® shows how innovative capabilities and expertise can address perfect fit for use, efficient processing as well as safe and easy administration for injectable medication. SCHOTT Pharma’s expertise in drug containment and delivery solutions and Ypsomed’s expertise in injection systems make them the ideal partners to present their joint solution in this session. Learn more about your ad choices. Visit megaphone.fm/adchoices The combination of YpsoDose and the 10 mL cartriQ® shows how innovative capabilities and expertise can address perfect fit for use, efficient processing as well as safe and easy administration for injectable medication. SCHOTT Pharma’s expertise in drug containment and delivery solutions and Ypsomed’s expertise in injection systems make them the ideal partners to present their joint solution in this session.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 975 no Key aspects when selecting a prefilled syringe Launching a drug into a prefilled syringe has many advantages. Prefilled syringes eliminate some of the drug preparation steps and therefore reduce the risk for medical errors and safe valuable time for health care professionals to focus on patients. However, selecting the right prefillable syringe, being a complex drug delivery system, is not an easy task. Knowing available materials, the key differences among them and their implications can help you in making your prefilled syringe decision. Join the webinar to gain more insights. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 09:00:00 -0000 Key aspects when selecting a prefilled syringe full SCHOTT Pharma Launching a drug into a prefilled syringe has many advantages. Prefilled syringes eliminate some of the drug preparation steps and therefore reduce the risk for medical errors and safe valuable time for health care professionals to focus on patients. However, selecting the right prefillable syringe, being a complex drug delivery system, is not an easy task. Knowing available materials, the key differences among them and their implications can help you in making your prefilled syringe decision. Join the webinar to gain more insights. Learn more about your ad choices. Visit megaphone.fm/adchoices Launching a drug into a prefilled syringe has many advantages. Prefilled syringes eliminate some of the drug preparation steps and therefore reduce the risk for medical errors and safe valuable time for health care professionals to focus on patients. However, selecting the right prefillable syringe, being a complex drug delivery system, is not an easy task. Knowing available materials, the key differences among them and their implications can help you in making your prefilled syringe decision. Join the webinar to gain more insights.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1537 no Adjusting pharmaceutical containers’ for biologics and other sensitive drugs Protecting medication from undesired interactions with the surrounding environment and preserving their efficacy during shelf life is one of the most pressing challenges for the pharmaceutical industry. Specially developed inner coating solutions, such as SCHOTT TopLyo® and SCHOTT Type I plus® may fit to the specific needs in your drug development cycle. These functional coatings applied to the inner surface of a pharmaceutical container make it more suitable for biologics and all other highly sensitive drugs. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Adjusting pharmaceutical containers’ for biologics and other sensitive drugs full SCHOTT Pharma Protecting medication from undesired interactions with the surrounding environment and preserving their efficacy during shelf life is one of the most pressing challenges for the pharmaceutical industry. Specially developed inner coating solutions, such as SCHOTT TopLyo® and SCHOTT Type I plus® may fit to the specific needs in your drug development cycle. These functional coatings applied to the inner surface of a pharmaceutical container make it more suitable for biologics and all other highly sensitive drugs. Learn more about your ad choices. Visit megaphone.fm/adchoices Protecting medication from undesired interactions with the surrounding environment and preserving their efficacy during shelf life is one of the most pressing challenges for the pharmaceutical industry. Specially developed inner coating solutions, such as SCHOTT TopLyo® and SCHOTT Type I plus® may fit to the specific needs in your drug development cycle. These functional coatings applied to the inner surface of a pharmaceutical container make it more suitable for biologics and all other highly sensitive drugs.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 963 no Minimizing medical errors in emergency situations - SCHOTT TOPPAC® infuse Intravenous medications are a pivotal drug class that are used in many critical hospital treatments, for example on ICUs or in Operation Rooms. In these surroundings, the risk for medical errors, such as giving the wrong drug or the wrong dose can create a life-threatening situation for the patient. Especially in emergencies, the drug administration often has to be done very fast and, thus, time-consuming multi-step preparation by health care professionals need to be minimized. Pre-filled containers, and here particularly pre-filled syringes, are a highly preferred solution by the hospital staff to avoid exactly these kind of errors that could risk the patient’s lives. This session will evaluate what makes a high-quality COC pre-filled syringe being an easy-to-use-solution, outlining not only the advantages of COC as a material, but also discuss the compatibility with key hospital devices, such as syringe pumps and needless connectors and additional innovative solutions like tamper evidence. The session will also show how the general trend in the field of compounding to switch to high-quality pre-filled containers improves the overall drug shelf life, ease of use for nurses and physicians as well as the overall patient safety for various medications in this field. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Minimizing medical errors in emergency situations - SCHOTT TOPPAC® infuse full SCHOTT Pharma Intravenous medications are a pivotal drug class that are used in many critical hospital treatments, for example on ICUs or in Operation Rooms. In these surroundings, the risk for medical errors, such as giving the wrong drug or the wrong dose can create a life-threatening situation for the patient. Especially in emergencies, the drug administration often has to be done very fast and, thus, time-consuming multi-step preparation by health care professionals need to be minimized. Pre-filled containers, and here particularly pre-filled syringes, are a highly preferred solution by the hospital staff to avoid exactly these kind of errors that could risk the patient’s lives. This session will evaluate what makes a high-quality COC pre-filled syringe being an easy-to-use-solution, outlining not only the advantages of COC as a material, but also discuss the compatibility with key hospital devices, such as syringe pumps and needless connectors and additional innovative solutions like tamper evidence. The session will also show how the general trend in the field of compounding to switch to high-quality pre-filled containers improves the overall drug shelf life, ease of use for nurses and physicians as well as the overall patient safety for various medications in this field. Learn more about your ad choices. Visit megaphone.fm/adchoices Intravenous medications are a pivotal drug class that are used in many critical hospital treatments, for example on ICUs or in Operation Rooms. In these surroundings, the risk for medical errors, such as giving the wrong drug or the wrong dose can create a life-threatening situation for the patient. Especially in emergencies, the drug administration often has to be done very fast and, thus, time-consuming multi-step preparation by health care professionals need to be minimized. Pre-filled containers, and here particularly pre-filled syringes, are a highly preferred solution by the hospital staff to avoid exactly these kind of errors that could risk the patient’s lives. This session will evaluate what makes a high-quality COC pre-filled syringe being an easy-to-use-solution, outlining not only the advantages of COC as a material, but also discuss the compatibility with key hospital devices, such as syringe pumps and needless connectors and additional innovative solutions like tamper evidence. The session will also show how the general trend in the field of compounding to switch to high-quality pre-filled containers improves the overall drug shelf life, ease of use for nurses and physicians as well as the overall patient safety for various medications in this field.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1767 no Benefits of primary container customization with COC for devices With more and more drugs shifting to a homecare setting, drug delivery devices and wearables are getting increasingly important. To ensure that pharmaceutical packaging meets the specific requirements of these devices, including functionality and ease-of-use, SCHOTT offers to co-create individualized containers made out of cyclic olefin copolymer (COC) with its customers. With SCHOTT TOPPAC® unique, the customer is given the opportunity to co-develop a container around his existing device and not vice versa. So depending on the specific needs – for example, drug stability, fill & finish needs or compatibility – a novel primary container can be created without compromising on the device design. A defined 4-step sampling process reduces cost and overall project risk while allowing for reduced time-to-market. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Benefits of primary container customization with COC for devices full SCHOTT Pharma With more and more drugs shifting to a homecare setting, drug delivery devices and wearables are getting increasingly important. To ensure that pharmaceutical packaging meets the specific requirements of these devices, including functionality and ease-of-use, SCHOTT offers to co-create individualized containers made out of cyclic olefin copolymer (COC) with its customers. With SCHOTT TOPPAC® unique, the customer is given the opportunity to co-develop a container around his existing device and not vice versa. So depending on the specific needs – for example, drug stability, fill & finish needs or compatibility – a novel primary container can be created without compromising on the device design. A defined 4-step sampling process reduces cost and overall project risk while allowing for reduced time-to-market. Learn more about your ad choices. Visit megaphone.fm/adchoices With more and more drugs shifting to a homecare setting, drug delivery devices and wearables are getting increasingly important. To ensure that pharmaceutical packaging meets the specific requirements of these devices, including functionality and ease-of-use, SCHOTT offers to co-create individualized containers made out of cyclic olefin copolymer (COC) with its customers. With SCHOTT TOPPAC® unique, the customer is given the opportunity to co-develop a container around his existing device and not vice versa. So depending on the specific needs – for example, drug stability, fill & finish needs or compatibility – a novel primary container can be created without compromising on the device design. A defined 4-step sampling process reduces cost and overall project risk while allowing for reduced time-to-market.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1077 no Particle reduction with ready-to-use vials in the entire value chain Sterile injectable drugs play a crucial role in the treatment of disease. All stakeholders in this industry have the inherent goal to make injectable drugs safe and effective. This includes an expectation that every lot be essentially free from visible particulates, and that manufacturers strive to minimize all particulate and foreign contamination. In this Webinar, we reveal how we reduce particles in ready-to-use packaging by aligning lid material, adhesive and sealing parameters based on a scientific study performed in 2019. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Particle reduction with ready-to-use vials in the entire value chain full SCHOTT Pharma Sterile injectable drugs play a crucial role in the treatment of disease. All stakeholders in this industry have the inherent goal to make injectable drugs safe and effective. This includes an expectation that every lot be essentially free from visible particulates, and that manufacturers strive to minimize all particulate and foreign contamination. In this Webinar, we reveal how we reduce particles in ready-to-use packaging by aligning lid material, adhesive and sealing parameters based on a scientific study performed in 2019. Learn more about your ad choices. Visit megaphone.fm/adchoices Sterile injectable drugs play a crucial role in the treatment of disease. All stakeholders in this industry have the inherent goal to make injectable drugs safe and effective. This includes an expectation that every lot be essentially free from visible particulates, and that manufacturers strive to minimize all particulate and foreign contamination. In this Webinar, we reveal how we reduce particles in ready-to-use packaging by aligning lid material, adhesive and sealing parameters based on a scientific study performed in 2019.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1850 no Maximizing fill-and-finish flexibility with RTU vials adaptiQ® offers proven SCHOTT vials in a modularized ready-to-use configuration. This session will focus on how our new packaging options can help you to increase manufacturing flexibility and improving TCO. All while ensuring patient safety. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Maximizing fill-and-finish flexibility with RTU vials full SCHOTT Pharma adaptiQ® offers proven SCHOTT vials in a modularized ready-to-use configuration. This session will focus on how our new packaging options can help you to increase manufacturing flexibility and improving TCO. All while ensuring patient safety. Learn more about your ad choices. Visit megaphone.fm/adchoices adaptiQ® offers proven SCHOTT vials in a modularized ready-to-use configuration. This session will focus on how our new packaging options can help you to increase manufacturing flexibility and improving TCO. All while ensuring patient safety.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1401 no Increasing flexibility for fast changeovers between various container types Efficiency and flexibility is key in pharmaceutical fill & finish settings. Especially when facing smaller batch sizes. In these environments quick change overs from one drug to another are of utmost importance. But what if the transition does not only cover various drug types, but also require filling of various container types? Be invited to the Groninger Showroom in Crailsheim where Marius Römer (Groninger co GmbH) and Christian Arends (SCHOTT Pharmaceutical systems) demonstrate format part changeovers in real time and explain how flexible filling machines in combination with RTU containers can improve your fill and finish processes. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Increasing flexibility for fast changeovers between various container types full SCHOTT Pharma Efficiency and flexibility is key in pharmaceutical fill & finish settings. Especially when facing smaller batch sizes. In these environments quick change overs from one drug to another are of utmost importance. But what if the transition does not only cover various drug types, but also require filling of various container types? Be invited to the Groninger Showroom in Crailsheim where Marius Römer (Groninger co GmbH) and Christian Arends (SCHOTT Pharmaceutical systems) demonstrate format part changeovers in real time and explain how flexible filling machines in combination with RTU containers can improve your fill and finish processes. Learn more about your ad choices. Visit megaphone.fm/adchoices Efficiency and flexibility is key in pharmaceutical fill & finish settings. Especially when facing smaller batch sizes. In these environments quick change overs from one drug to another are of utmost importance. But what if the transition does not only cover various drug types, but also require filling of various container types? Be invited to the Groninger Showroom in Crailsheim where Marius Römer (Groninger co GmbH) and Christian Arends (SCHOTT Pharmaceutical systems) demonstrate format part changeovers in real time and explain how flexible filling machines in combination with RTU containers can improve your fill and finish processes.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1370 no The main advantages of prefilled syringes Medication errors and shortages of drugs are some of the most urgent issues at hospitals. The WHO estimates the total global costs of medication errors are 42 Billion USD per year. On the other hand, drug shortages may adversely affect patient care by compromising or delaying medical procedures and are becoming more frequent globally.This session will explore how polymer pre-fillable syringes can help hospital pharmacies and compounding centers to reduce drug shortages and save costs for hospitals and health care system while increasing patient safety. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 The main advantages of prefilled syringes full SCHOTT Pharma Medication errors and shortages of drugs are some of the most urgent issues at hospitals. The WHO estimates the total global costs of medication errors are 42 Billion USD per year. On the other hand, drug shortages may adversely affect patient care by compromising or delaying medical procedures and are becoming more frequent globally.This session will explore how polymer pre-fillable syringes can help hospital pharmacies and compounding centers to reduce drug shortages and save costs for hospitals and health care system while increasing patient safety. Learn more about your ad choices. Visit megaphone.fm/adchoices Medication errors and shortages of drugs are some of the most urgent issues at hospitals. The WHO estimates the total global costs of medication errors are 42 Billion USD per year. On the other hand, drug shortages may adversely affect patient care by compromising or delaying medical procedures and are becoming more frequent globally.
This session will explore how polymer pre-fillable syringes can help hospital pharmacies and compounding centers to reduce drug shortages and save costs for hospitals and health care system while increasing patient safety.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1490 no Identifying origins for glass breakage to optimize filling lines Glass is a strong material, but it can be sensitive if handled inadequately. SmartSkin’s Quantifeel pressure-sensing drones and SCHOTT’s glass analytics are powerful tools for identifying, localizing and verifying the root causes of breakage – helping to prevent unnecessary downtime and contributing to line optimization. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Identifying origins for glass breakage to optimize filling lines full SCHOTT Pharma Glass is a strong material, but it can be sensitive if handled inadequately. SmartSkin’s Quantifeel pressure-sensing drones and SCHOTT’s glass analytics are powerful tools for identifying, localizing and verifying the root causes of breakage – helping to prevent unnecessary downtime and contributing to line optimization. Learn more about your ad choices. Visit megaphone.fm/adchoices Glass is a strong material, but it can be sensitive if handled inadequately. SmartSkin’s Quantifeel pressure-sensing drones and SCHOTT’s glass analytics are powerful tools for identifying, localizing and verifying the root causes of breakage – helping to prevent unnecessary downtime and contributing to line optimization.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1270 no Achieving and assuring sterility in ready-to-use pharmaceutical packaging Sterility is the most critical parameter in ready-to-use packaging. As it depends not only on efficient processes but also on the involved packaging materials, choosing the appropriate sterilization technique is crucial to assure safe packaging components. Furthermore, sterile integrity of the primary packaging components has to be maintained during introduction and processing in an aseptic fill + finish environment. In this webcast, the audience will learn about typically used sterilization technologies, the underlying processes and understand which risks and benefits are associated with them. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Achieving and assuring sterility in ready-to-use pharmaceutical packaging full SCHOTT Pharma Sterility is the most critical parameter in ready-to-use packaging. As it depends not only on efficient processes but also on the involved packaging materials, choosing the appropriate sterilization technique is crucial to assure safe packaging components. Furthermore, sterile integrity of the primary packaging components has to be maintained during introduction and processing in an aseptic fill + finish environment. In this webcast, the audience will learn about typically used sterilization technologies, the underlying processes and understand which risks and benefits are associated with them. Learn more about your ad choices. Visit megaphone.fm/adchoices Sterility is the most critical parameter in ready-to-use packaging. As it depends not only on efficient processes but also on the involved packaging materials, choosing the appropriate sterilization technique is crucial to assure safe packaging components. Furthermore, sterile integrity of the primary packaging components has to be maintained during introduction and processing in an aseptic fill + finish environment. In this webcast, the audience will learn about typically used sterilization technologies, the underlying processes and understand which risks and benefits are associated with them.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1041 no The advantages of strength-optimized vials with an outer coating Rejects and disruptions during pharmaceutical fill-and-finish operations are a main root cause for inefficient drug manufacturing. This is particularly relevant as the standard bulk filling process typically introduces cosmetic defects, such as scratches or abrasions, to the vials, leading to increased reject rates of the final product or even fatal events like glass breakage. EVERIC® strong & smooth vials have an optimized strength, combined with an outer coating, that reduces the friction and allows the containers to run smoothly through production. In this session, the focus will be on the superior coating process. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 The advantages of strength-optimized vials with an outer coating full SCHOTT Pharma Rejects and disruptions during pharmaceutical fill-and-finish operations are a main root cause for inefficient drug manufacturing. This is particularly relevant as the standard bulk filling process typically introduces cosmetic defects, such as scratches or abrasions, to the vials, leading to increased reject rates of the final product or even fatal events like glass breakage. EVERIC® strong & smooth vials have an optimized strength, combined with an outer coating, that reduces the friction and allows the containers to run smoothly through production. In this session, the focus will be on the superior coating process. Learn more about your ad choices. Visit megaphone.fm/adchoices Rejects and disruptions during pharmaceutical fill-and-finish operations are a main root cause for inefficient drug manufacturing. This is particularly relevant as the standard bulk filling process typically introduces cosmetic defects, such as scratches or abrasions, to the vials, leading to increased reject rates of the final product or even fatal events like glass breakage. EVERIC® strong & smooth vials have an optimized strength, combined with an outer coating, that reduces the friction and allows the containers to run smoothly through production. In this session, the focus will be on the superior coating process.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 896 no mRNA applications – From vial to prefilled syringe COVID-19 has brought the mRNA era into existence. Biotechs that have been working on the technology for years are now ready for liftoff, with vaccines and therapeutics for a range of diseases from flu to cystic fibrosis.  But the technology comes with storage and transport limitations driven by the fragility of the lipid nanoparticles (LNPs) that function as mRNA delivery systems.  Deep cold temperature conditions and consecutive, unpredictable free-thaw cycles may impact the functional performance, mechanical stability, container closure integrity, sterility and particulate levels of the drug container.  These risks raise important questions about the safety of different primary packaging formats, and must be fully understood to launch mRNA drugs with confidence.In this session, we will discuss test data for syriQ® glass syringes, demonstrating robust performance down to -50°C and highlighting the importance of complex component and materials interaction in the pre-filled syringe system.  Our results confirm the suitability of syriQ® glass pre-filled syringes as a primary packaging solution for mRNA and other applications requiring cold storage down to -50°C.  This allows drug manufacturers to exploit the benefits that come with glass of established manufacturing networks, multiple supply sources, and a clear regulatory path. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 mRNA applications – From vial to prefilled syringe full SCHOTT Pharma COVID-19 has brought the mRNA era into existence. Biotechs that have been working on the technology for years are now ready for liftoff, with vaccines and therapeutics for a range of diseases from flu to cystic fibrosis.  But the technology comes with storage and transport limitations driven by the fragility of the lipid nanoparticles (LNPs) that function as mRNA delivery systems.  Deep cold temperature conditions and consecutive, unpredictable free-thaw cycles may impact the functional performance, mechanical stability, container closure integrity, sterility and particulate levels of the drug container.  These risks raise important questions about the safety of different primary packaging formats, and must be fully understood to launch mRNA drugs with confidence.In this session, we will discuss test data for syriQ® glass syringes, demonstrating robust performance down to -50°C and highlighting the importance of complex component and materials interaction in the pre-filled syringe system.  Our results confirm the suitability of syriQ® glass pre-filled syringes as a primary packaging solution for mRNA and other applications requiring cold storage down to -50°C.  This allows drug manufacturers to exploit the benefits that come with glass of established manufacturing networks, multiple supply sources, and a clear regulatory path. Learn more about your ad choices. Visit megaphone.fm/adchoices COVID-19 has brought the mRNA era into existence. Biotechs that have been working on the technology for years are now ready for liftoff, with vaccines and therapeutics for a range of diseases from flu to cystic fibrosis.  But the technology comes with storage and transport limitations driven by the fragility of the lipid nanoparticles (LNPs) that function as mRNA delivery systems.  Deep cold temperature conditions and consecutive, unpredictable free-thaw cycles may impact the functional performance, mechanical stability, container closure integrity, sterility and particulate levels of the drug container.  These risks raise important questions about the safety of different primary packaging formats, and must be fully understood to launch mRNA drugs with confidence.
In this session, we will discuss test data for syriQ® glass syringes, demonstrating robust performance down to -50°C and highlighting the importance of complex component and materials interaction in the pre-filled syringe system.  Our results confirm the suitability of syriQ® glass pre-filled syringes as a primary packaging solution for mRNA and other applications requiring cold storage down to -50°C.  This allows drug manufacturers to exploit the benefits that come with glass of established manufacturing networks, multiple supply sources, and a clear regulatory path.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 871 no How can PFS‘ help to optimize drug preparation? According to an evaluation of the WHO, medication errors cause at least one death every day and injure approximately 1.3 million people annually in the US alone.  Apart from harming patients, medication errors also drive up the costs for the health care system. Adverse drug events in US community hospitals cost more than 3,000 USD per incident on average and lead to a median increase of hospital length of stay of 3.1 days. On the other hand, drug shortages may adversely affect patient care by compromising or delaying medical procedures. High quality pre-filled syringes make the drug administration process much faster, easier and safer.In this joint session with AST, leader in aseptic manufacturing processes, we will break down the daunting challenge of selecting the right pre-fillable syringe and how to process it on an automated, high speed filling line, contributing thus to reduce drug shortages and save costs for hospitals and the health care system. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 How can PFS‘ help to optimize drug preparation? full SCHOTT Pharma According to an evaluation of the WHO, medication errors cause at least one death every day and injure approximately 1.3 million people annually in the US alone.  Apart from harming patients, medication errors also drive up the costs for the health care system. Adverse drug events in US community hospitals cost more than 3,000 USD per incident on average and lead to a median increase of hospital length of stay of 3.1 days. On the other hand, drug shortages may adversely affect patient care by compromising or delaying medical procedures. High quality pre-filled syringes make the drug administration process much faster, easier and safer.In this joint session with AST, leader in aseptic manufacturing processes, we will break down the daunting challenge of selecting the right pre-fillable syringe and how to process it on an automated, high speed filling line, contributing thus to reduce drug shortages and save costs for hospitals and the health care system. Learn more about your ad choices. Visit megaphone.fm/adchoices According to an evaluation of the WHO, medication errors cause at least one death every day and injure approximately 1.3 million people annually in the US alone.  Apart from harming patients, medication errors also drive up the costs for the health care system. Adverse drug events in US community hospitals cost more than 3,000 USD per incident on average and lead to a median increase of hospital length of stay of 3.1 days. On the other hand, drug shortages may adversely affect patient care by compromising or delaying medical procedures. High quality pre-filled syringes make the drug administration process much faster, easier and safer.

In this joint session with AST, leader in aseptic manufacturing processes, we will break down the daunting challenge of selecting the right pre-fillable syringe and how to process it on an automated, high speed filling line, contributing thus to reduce drug shortages and save costs for hospitals and the health care system.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1145 no Vials for biologics Due to large, complex and therefore sensitive molecules, biologics pose a challenge to standard drug containment solutions. Their sensitivity towards leachables, the necessity of lyophilization or their tendency to adsorb might require a special inner glass surface quality. Storage at deep cold temperatures pose additional challenges with regard to container closure integrity and strength. Their high value put even more pressure on the reduction of final rejects and on the ability for track-and-trace on unique container level. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Vials for biologics full SCHOTT Pharma Due to large, complex and therefore sensitive molecules, biologics pose a challenge to standard drug containment solutions. Their sensitivity towards leachables, the necessity of lyophilization or their tendency to adsorb might require a special inner glass surface quality. Storage at deep cold temperatures pose additional challenges with regard to container closure integrity and strength. Their high value put even more pressure on the reduction of final rejects and on the ability for track-and-trace on unique container level. Learn more about your ad choices. Visit megaphone.fm/adchoices Due to large, complex and therefore sensitive molecules, biologics pose a challenge to standard drug containment solutions. Their sensitivity towards leachables, the necessity of lyophilization or their tendency to adsorb might require a special inner glass surface quality. Storage at deep cold temperatures pose additional challenges with regard to container closure integrity and strength. Their high value put even more pressure on the reduction of final rejects and on the ability for track-and-trace on unique container level.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1062 no Assuring sterility of RTU containers from end-to-end When filling in aseptic environments, a strict contamination control is indispensable. This requires that all introduced components must be free from contamination. This also applies to the outer packaging of ready-to-use containers, namely tub and Tyvek®, as these components enter the aseptic core before delidding of the tub to take out the primary packaging containers for filling.As the current market standard secondary packaging cannot assure the sterility of the outside of the tub and Tyvek®, pharma companies rely on cumbersome and expensive surface decontamination. The presentation will give details on improved packaging and machining concepts assuring sterility from end-to-end in a No-Touch-Transfer process. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 08:00:00 -0000 Assuring sterility of RTU containers from end-to-end full SCHOTT Pharma When filling in aseptic environments, a strict contamination control is indispensable. This requires that all introduced components must be free from contamination. This also applies to the outer packaging of ready-to-use containers, namely tub and Tyvek®, as these components enter the aseptic core before delidding of the tub to take out the primary packaging containers for filling.As the current market standard secondary packaging cannot assure the sterility of the outside of the tub and Tyvek®, pharma companies rely on cumbersome and expensive surface decontamination. The presentation will give details on improved packaging and machining concepts assuring sterility from end-to-end in a No-Touch-Transfer process. Learn more about your ad choices. Visit megaphone.fm/adchoices When filling in aseptic environments, a strict contamination control is indispensable. This requires that all introduced components must be free from contamination. This also applies to the outer packaging of ready-to-use containers, namely tub and Tyvek®, as these components enter the aseptic core before delidding of the tub to take out the primary packaging containers for filling.
As the current market standard secondary packaging cannot assure the sterility of the outside of the tub and Tyvek®, pharma companies rely on cumbersome and expensive surface decontamination. The presentation will give details on improved packaging and machining concepts assuring sterility from end-to-end in a No-Touch-Transfer process.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 816 no Efficient processing with EVERIC® strong & smooth Standard pharmaceutical bulk fill-and-finish processes can introduce various damages to containers starting from cosmetic defects (as scratches or abrasions) to occasional glass breakage, leading to rejects and disruptions during manufacturing. We also cover an introduction to our EVERIC® strong module that shows how the inherent strength of a vial can be increased by optimizing the geometry with in the ISO tolerances. EVERIC® smooth is one part of SCHOTT’s new modular vial concept, comprising an outer coating that aims to improve the overall processing performance on bulk production lines. In this webinar, the results of a comparative filling line trial with EVERIC® smooth vials at F. Hoffmann-La Roche will be presented. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 07:00:00 -0000 Efficient processing with EVERIC® strong & smooth full SCHOTT Pharma Standard pharmaceutical bulk fill-and-finish processes can introduce various damages to containers starting from cosmetic defects (as scratches or abrasions) to occasional glass breakage, leading to rejects and disruptions during manufacturing. We also cover an introduction to our EVERIC® strong module that shows how the inherent strength of a vial can be increased by optimizing the geometry with in the ISO tolerances. EVERIC® smooth is one part of SCHOTT’s new modular vial concept, comprising an outer coating that aims to improve the overall processing performance on bulk production lines. In this webinar, the results of a comparative filling line trial with EVERIC® smooth vials at F. Hoffmann-La Roche will be presented. Learn more about your ad choices. Visit megaphone.fm/adchoices Standard pharmaceutical bulk fill-and-finish processes can introduce various damages to containers starting from cosmetic defects (as scratches or abrasions) to occasional glass breakage, leading to rejects and disruptions during manufacturing. We also cover an introduction to our EVERIC® strong module that shows how the inherent strength of a vial can be increased by optimizing the geometry with in the ISO tolerances. EVERIC® smooth is one part of SCHOTT’s new modular vial concept, comprising an outer coating that aims to improve the overall processing performance on bulk production lines. In this webinar, the results of a comparative filling line trial with EVERIC® smooth vials at F. Hoffmann-La Roche will be presented.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1476 no Strength of primary packaging glass containers Cracking or breakage of primary packaging glass containers is an annoying incidence that can cause numerous unpleasant consequences, such as down time of fill & finish lines, vendor and customer complaints, right up to market recalls. In most cases, cracking or breakage of glass is the result of improper handling or processing and/or excessive mechanical loading. To better understand the mechanical strength of glass as primary packaging container, this webinar will cover the fundamental concepts of brittle failure with respect to the circumstances and conditions of the pharmaceutical industry. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 07:00:00 -0000 Strength of primary packaging glass containers full SCHOTT Pharma Cracking or breakage of primary packaging glass containers is an annoying incidence that can cause numerous unpleasant consequences, such as down time of fill & finish lines, vendor and customer complaints, right up to market recalls. In most cases, cracking or breakage of glass is the result of improper handling or processing and/or excessive mechanical loading. To better understand the mechanical strength of glass as primary packaging container, this webinar will cover the fundamental concepts of brittle failure with respect to the circumstances and conditions of the pharmaceutical industry. Learn more about your ad choices. Visit megaphone.fm/adchoices Cracking or breakage of primary packaging glass containers is an annoying incidence that can cause numerous unpleasant consequences, such as down time of fill & finish lines, vendor and customer complaints, right up to market recalls. In most cases, cracking or breakage of glass is the result of improper handling or processing and/or excessive mechanical loading. To better understand the mechanical strength of glass as primary packaging container, this webinar will cover the fundamental concepts of brittle failure with respect to the circumstances and conditions of the pharmaceutical industry.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 381 no Pharmaceutical labelling for prefilled syringes Pre-filled syringes made of high-quality Cyclic Olefin Copolymer (COC) have become a well-established alternative for administering drugs. Due to its properties and manufacturing process, COC is heavy metal and tungsten free and also exhibits low or no siliconization. However, the polymer also has a different E&L profile and a lower oxygen and gas barrier threshold than borosilicate glass, which increases the potential for drug interaction. These barrier properties are of concern when it comes to labeling. As adhesive labels are affixed directly to the container, there is a potential risk of adhesive migration into the polymer. This can be overcome by using functional labels, which even have the potential to enhance the primary packaging by adding specific functionalities –from overt or covert as well as analog and digital security features to effective first-opening indication - or specific protection through UV-blocking or enhanced gas barrier properties. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 07:00:00 -0000 Pharmaceutical labelling for prefilled syringes full SCHOTT Pharma Pre-filled syringes made of high-quality Cyclic Olefin Copolymer (COC) have become a well-established alternative for administering drugs. Due to its properties and manufacturing process, COC is heavy metal and tungsten free and also exhibits low or no siliconization. However, the polymer also has a different E&L profile and a lower oxygen and gas barrier threshold than borosilicate glass, which increases the potential for drug interaction. These barrier properties are of concern when it comes to labeling. As adhesive labels are affixed directly to the container, there is a potential risk of adhesive migration into the polymer. This can be overcome by using functional labels, which even have the potential to enhance the primary packaging by adding specific functionalities –from overt or covert as well as analog and digital security features to effective first-opening indication - or specific protection through UV-blocking or enhanced gas barrier properties. Learn more about your ad choices. Visit megaphone.fm/adchoices Pre-filled syringes made of high-quality Cyclic Olefin Copolymer (COC) have become a well-established alternative for administering drugs. Due to its properties and manufacturing process, COC is heavy metal and tungsten free and also exhibits low or no siliconization. However, the polymer also has a different E&L profile and a lower oxygen and gas barrier threshold than borosilicate glass, which increases the potential for drug interaction. These barrier properties are of concern when it comes to labeling. As adhesive labels are affixed directly to the container, there is a potential risk of adhesive migration into the polymer. This can be overcome by using functional labels, which even have the potential to enhance the primary packaging by adding specific functionalities –from overt or covert as well as analog and digital security features to effective first-opening indication - or specific protection through UV-blocking or enhanced gas barrier properties.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1774 no Smart Skin Technologies – Optimizing fill & finish performance Fill & Finish is the core of the pharmaceutical industry. Any interference of the production process causes trouble in delivering the drug on time in a flexible and easy way. For this, it is indispensable to know what is happening on production lines and what impact they have on primary packaging. Data can be a valuable source of gaining insights on the performance of lines as well as a helpful result of “pain points” of lines and primary packaging containers. SmartSkin provides drones for pressure management on filling and packaging lines. With the strong cooperation between SCHOTT & SmartSkin you can optimize the fill & finish performance to reduce glass breakage, bruising and micro fractures. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 07:00:00 -0000 Smart Skin Technologies – Optimizing fill & finish performance full SCHOTT Pharma Fill & Finish is the core of the pharmaceutical industry. Any interference of the production process causes trouble in delivering the drug on time in a flexible and easy way. For this, it is indispensable to know what is happening on production lines and what impact they have on primary packaging. Data can be a valuable source of gaining insights on the performance of lines as well as a helpful result of “pain points” of lines and primary packaging containers. SmartSkin provides drones for pressure management on filling and packaging lines. With the strong cooperation between SCHOTT & SmartSkin you can optimize the fill & finish performance to reduce glass breakage, bruising and micro fractures. Learn more about your ad choices. Visit megaphone.fm/adchoices Fill & Finish is the core of the pharmaceutical industry. Any interference of the production process causes trouble in delivering the drug on time in a flexible and easy way. For this, it is indispensable to know what is happening on production lines and what impact they have on primary packaging. Data can be a valuable source of gaining insights on the performance of lines as well as a helpful result of “pain points” of lines and primary packaging containers. SmartSkin provides drones for pressure management on filling and packaging lines. With the strong cooperation between SCHOTT & SmartSkin you can optimize the fill & finish performance to reduce glass breakage, bruising and micro fractures.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 973 no Primary packaging for cryogenics Advances in cryopreservation lead to new challenges in the field of pharmaceutical packaging. While it keeps the drug in a stable state, allows for longer shelf life, and ensures stability throughout the supply chain, manufacturers must plan for the unique challenges for vial-based container closure systems. In this session, our experts will share their study results in regards to container closure integrity at cryo temperatures. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Jul 2023 07:00:00 -0000 Primary packaging for cryogenics full SCHOTT Pharma Advances in cryopreservation lead to new challenges in the field of pharmaceutical packaging. While it keeps the drug in a stable state, allows for longer shelf life, and ensures stability throughout the supply chain, manufacturers must plan for the unique challenges for vial-based container closure systems. In this session, our experts will share their study results in regards to container closure integrity at cryo temperatures. Learn more about your ad choices. Visit megaphone.fm/adchoices Advances in cryopreservation lead to new challenges in the field of pharmaceutical packaging. While it keeps the drug in a stable state, allows for longer shelf life, and ensures stability throughout the supply chain, manufacturers must plan for the unique challenges for vial-based container closure systems. In this session, our experts will share their study results in regards to container closure integrity at cryo temperatures.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 977 no Full delamination control with EVERIC® pure This session addresses the market trend to individualizing primary packaging containers to the requirements of different drug formulations. Here, we show results (from studies of controlling delamination even) of stability studies of relevant biologic buffers and Water-for-injection with low-filling volumes in vials. A comparative study with standard vials will explain outstanding results. Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 17 Jul 2023 15:00:00 -0000 Full delamination control with EVERIC® pure full SCHOTT Pharma This session addresses the market trend to individualizing primary packaging containers to the requirements of different drug formulations. Here, we show results (from studies of controlling delamination even) of stability studies of relevant biologic buffers and Water-for-injection with low-filling volumes in vials. A comparative study with standard vials will explain outstanding results. Learn more about your ad choices. Visit megaphone.fm/adchoices This session addresses the market trend to individualizing primary packaging containers to the requirements of different drug formulations. Here, we show results (from studies of controlling delamination even) of stability studies of relevant biologic buffers and Water-for-injection with low-filling volumes in vials. A comparative study with standard vials will explain outstanding results.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1899 no